RNA-based therapeutic inhibits a metabolic pathway in tumor-initiating lung cancer cells
RNA-based therapeutics that prevent a key metabolic enzyme from being expressed in tumor-initiating cells (TIC) hold promise for the treatment of lung cancer, an A*STAR team has shown.
Mar 23, 2018
0
10